These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10958304)

  • 21. Expression of CD40 and apoptosis related molecules in autoimmune thyroid diseases.
    Kie JH; Cho MS; Yang WI
    Yonsei Med J; 2001 Oct; 42(5):488-96. PubMed ID: 11675676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-thionamide antithyroid drug options in Graves' hyperthyroidism.
    Ruslan A; Okosieme OE
    Expert Rev Endocrinol Metab; 2023 Jan; 18(1):67-79. PubMed ID: 36740774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of Fas expression and down-regulation of Fas ligand in highly aggressive human thyroid carcinoma.
    Basolo F; Fiore L; Baldanzi A; Giannini R; Dell'Omodarme M; Fontanini G; Pacini F; Danesi R; Miccoli P; Toniolo A
    Lab Invest; 2000 Sep; 80(9):1413-9. PubMed ID: 11005209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression.
    Aguayo J; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyrocyte proliferation by cellular adhesion to infiltrating lymphocytes through the intercellular adhesion molecule-1/lymphocyte function-associated antigen-1 pathway in Graves' disease.
    Arao T; Morimoto I; Kakinuma A; Ishida O; Zeki K; Tanaka Y; Ishikawa N; Ito K; Ito K; Eto S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):382-9. PubMed ID: 10634414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of apoptosis-related proteins in Hashimoto's thyroiditis and its pathological significance].
    Zhang Y; Ji Q; Zhang W
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):432-4. PubMed ID: 11798914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease.
    Zantut-Wittmann DE; Tambascia MA; da Silva Trevisan MA; Pinto GA; Vassallo J
    Thyroid; 2001 Jun; 11(6):575-80. PubMed ID: 11442005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathyroidal CD4+ T lymphocytes express high levels of Fas and CD4+ CD8+ macrophages/dendritic cells express Fas ligand in autoimmune thyroid disease.
    Nakamura Y; Watanabe M; Matsuzuka F; Maruoka H; Miyauchi A; Iwatani Y
    Thyroid; 2004 Oct; 14(10):819-24. PubMed ID: 15588377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.
    Mitsiades N; Poulaki V; Kotoula V; Mastorakos G; Tseleni-Balafouta S; Koutras DA; Tsokos M
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2199-203. PubMed ID: 9626160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lower proportion of intra-thyroidal B lymphocytes CD20
    Barros Silva AC; Damas II; Moma CA; Barreto IS; Zantut-Wittmann DE
    Mol Cell Endocrinol; 2024 Oct; 592():112331. PubMed ID: 39029780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical analysis of bcl-2, Bax and Bak expression in thyroid glands from patients with Graves' disease.
    Hiromatsu Y; Kaku H; Mukai T; Miyake I; Fukutani T; Koga M; Shoji S; Toda S; Koike N
    Endocr J; 2004 Aug; 51(4):399-405. PubMed ID: 15351796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating soluble Fas ligand correlates with disease activity in Graves' hyperthyroidism.
    Wang CY; Zhong WB; Chang TC; Tsai YF
    Metabolism; 2002 Jun; 51(6):769-73. PubMed ID: 12037733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fas-Mediated apoptosis is inhibited by TSH and iodine in moderate concentrations in primary human thyrocytes in vitro.
    Feldkamp J; Pascher E; Perniok A; Scherbaum WA
    Horm Metab Res; 1999 Jun; 31(6):355-8. PubMed ID: 10437622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Tezuka H; Nakao H; Kawakami A; Migita K; Ishikawa
    J Clin Endocrinol Metab; 1989 Nov; 69(5):939-45. PubMed ID: 2793996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No association between Fas A/G polymorphism and therapeutic effects induced by methimazole treatment for Graves' disease in Northern Chinese.
    Li P; Li Q; Chen L; Sun Y; Zhang J
    Pharmazie; 2008 Oct; 63(10):748-50. PubMed ID: 18972838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
    O'Connell J; Bennett MW; O'Sullivan GC; Roche D; Kelly J; Collins JK; Shanahan F
    J Pathol; 1998 Nov; 186(3):240-6. PubMed ID: 10211111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of stromal-derived factor 1 in autonomous thyroid adenomas and its regulation in thyroid-derived cells.
    Aust G; Steinert M; Kiessling S; Kamprad M; Simchen C
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3368-76. PubMed ID: 11443213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.